FARMERS & MERCHANTS TRUST Co OF LONG BEACH Acquires Shares of 2,947 Solventum Co. (NYSE:SOLV)

FARMERS & MERCHANTS TRUST Co OF LONG BEACH bought a new stake in shares of Solventum Co. (NYSE:SOLVFree Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 2,947 shares of the company’s stock, valued at approximately $205,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Deseret Mutual Benefit Administrators acquired a new position in shares of Solventum in the 2nd quarter worth approximately $25,000. Hollencrest Capital Management acquired a new position in Solventum in the second quarter worth $25,000. Partnership Wealth Management LLC bought a new stake in Solventum during the second quarter valued at $26,000. Richard W. Paul & Associates LLC acquired a new stake in shares of Solventum during the second quarter worth $26,000. Finally, Family Firm Inc. acquired a new position in shares of Solventum in the 2nd quarter valued at about $26,000.

Analyst Ratings Changes

Several research firms recently weighed in on SOLV. The Goldman Sachs Group increased their price objective on shares of Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a research note on Monday, August 12th. Argus assumed coverage on Solventum in a research report on Monday, June 24th. They set a “hold” rating on the stock. Piper Sandler started coverage on Solventum in a research report on Monday, October 7th. They set a “neutral” rating and a $71.00 price objective for the company. BTIG Research began coverage on Solventum in a research note on Thursday, September 5th. They set a “neutral” rating for the company. Finally, Wells Fargo & Company cut their target price on Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Friday, August 9th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $64.33.

View Our Latest Report on SOLV

Solventum Trading Up 0.1 %

Shares of NYSE:SOLV opened at $68.14 on Friday. The company has a debt-to-equity ratio of 2.90, a current ratio of 1.31 and a quick ratio of 0.96. The firm’s fifty day moving average is $64.77. Solventum Co. has a one year low of $47.16 and a one year high of $96.05.

Solventum (NYSE:SOLVGet Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.10. The company had revenue of $2.08 billion during the quarter, compared to analysts’ expectations of $2.05 billion. Solventum’s quarterly revenue was up .2% on a year-over-year basis. As a group, equities research analysts anticipate that Solventum Co. will post 6.38 earnings per share for the current fiscal year.

Solventum Profile

(Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Featured Stories

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Co. (NYSE:SOLVFree Report).

Institutional Ownership by Quarter for Solventum (NYSE:SOLV)

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.